ClinicalTrials.Veeva

Menu

Clinical Effectiveness of Microwave Ablation Using Starwave Microwave Generator for Hepatic Malignancies

Seoul National University logo

Seoul National University

Status

Enrolling

Conditions

Liver Malignant Tumors

Treatments

Procedure: Microwave ablation

Study type

Interventional

Funder types

Other

Identifiers

NCT06426992
2402-111-151

Details and patient eligibility

About

The purpose of this study is to determine the technical success rate of creating a safety margin of 5 mm or more including the tumor by performing image-guided percutaneous microwave thermal therapy using a microwave generator and antenna developed by StarMed for the treatment of small liver cancer and the 1-year local recurrence rate based on follow-up imaging tests.

Enrollment

62 estimated patients

Sex

All

Ages

20 to 85 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Child-Pugh Class A or B
  • Patients with suspected hepatocellular carcinoma or residual/recurrent hepatocellular carcinoma of 4 cm or less on MDCT, CEUS, or MRI performed within the last 60 days or Patients with suspected metastatic liver cancer of 4 cm or less on MDCT, CEUS, or MRI performed within the last 60 days, for whom microwave thermal ablation is being considered

Exclusion criteria

  • In cases where there are three or more malignant liver tumors
  • When the maximum size of the tumor exceeds 4 cm
  • Diffuse infiltrative type of cancer with unclear tumor boundaries
  • When the tumor is adhered to the central hepatic portal vein, hepatic vein, or bile duct by 5 mm or more
  • Severe liver failure (Child-Pugh Class C)
  • In cases of vascular invasion by malignant liver tumors
  • Severe coagulopathy (platelet count below 50,000/mm³ or INR prolonged by more than 50%)
  • In cases of multiple extrahepatic metastases
  • Situations where it is highly unlikely to obtain appropriate data for research purposes

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

62 participants in 1 patient group

Patients with malignant liver tumors
Experimental group
Description:
Following the existing procedure of our institute, we aim to treat the tumor by applying up to 150W of microwaves within the tumor using a StarWave microwave generator and a 13-gauge antenna under fusion ultrasound guidance. If necessary, the antenna is reinserted 1-2 times to create sufficient ablation lesions until an echogenic band of 5-10mm is formed around the tumor and its periphery, implementing overlapping microwave ablation (MWA). Afterward, the antenna is removed while applying microwave energy to prevent bleeding.
Treatment:
Procedure: Microwave ablation

Trial contacts and locations

1

Loading...

Central trial contact

Hyun Hee Lee

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems